Health
Putting the ‘STING’ on CAR-T cells to turn them against breast cancer and other solid tumors – FierceBiotech
Activating the immune pathway STING creates an inflammatory environment that should improve immuno-oncology treatments, but clinical trials have been disappointing…
The immune pathway known as stimulator of interferon genes (STING) has long been of interest in the oncology community because activating it creates an inflammatory environment that should improve the ability of immune cells to attack cancer. But experimental STING-activating treatments have produced mixed results in clinical trials.
Researchers at the University of North Carolina (UNC) Lineberger Comprehensive Cancer Center have promising evidence that adding STING activators to CAR-T cell therapies…
-
Business16 hours agoThink Nvidia stock is expensive? This chart might change your mind.
-
Noosa News16 hours agoQLD Gives more than $150K to support grassroots Sunshine Coast charities
-
General23 hours agoThree dead after angry mob sets fire to parliament building in Indonesia
-
General23 hours agoIsabelle Kelly hospitalised with suspected broken jaw in Sydney Roosters’ NRLW win